Burning Rock Biotech (BNR) Assets (2021 - 2023)

Burning Rock Biotech has reported Assets over the past 3 years, most recently at $144.4 million for Q4 2023.

  • Quarterly results put Assets at $144.4 million for Q4 2023, down 35.29% from a year ago — trailing twelve months through Dec 2023 was $144.4 million (down 35.29% YoY), and the annual figure for FY2023 was $146.5 million, down 38.05%.
  • Assets for Q4 2023 was $144.4 million at Burning Rock Biotech, down from $223.2 million in the prior quarter.
  • Over the last five years, Assets for BNR hit a ceiling of $356.4 million in Q4 2021 and a floor of $144.4 million in Q4 2023.
  • Median Assets over the past 3 years was $223.2 million (2022), compared with a mean of $241.3 million.
  • Biggest five-year swings in Assets: crashed 37.37% in 2022 and later tumbled 35.29% in 2023.
  • Burning Rock Biotech's Assets stood at $356.4 million in 2021, then tumbled by 37.37% to $223.2 million in 2022, then tumbled by 35.29% to $144.4 million in 2023.
  • The last three reported values for Assets were $144.4 million (Q4 2023), $223.2 million (Q4 2022), and $356.4 million (Q4 2021) per Business Quant data.